Published in Microsc Res Tech on March 22, 2000
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. Mol Biol Cell (2007) 1.51
Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int J Exp Pathol (2003) 1.20
ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell (2004) 1.08
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. Cell Death Dis (2010) 0.99
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther (2010) 0.98
Ventilation during air breathing and in response to hypercapnia in 5 and 16 month-old mdx and C57 mice. J Muscle Res Cell Motil (2007) 0.91
Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int (2011) 0.88
Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation. Apoptosis (2006) 0.85
Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Mol Ther (2010) 0.83
Human muscular fetal cells: a potential cell source for muscular therapies. Pediatr Surg Int (2008) 0.83
Canine muscle cell culture and consecutive patch-clamp measurements - a new approach to characterize muscular diseases in dogs. BMC Vet Res (2012) 0.77
Harnessing the therapeutic potential of myogenic stem cells. Cytotechnology (2003) 0.77
Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Cell Transplant (2012) 0.77
Myoblast transplantation: a possible surgical treatment for a severe pediatric disease. Surg Today (2010) 0.76
DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy. Mol Ther (2010) 0.75
In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases. Stem Cells Int (2017) 0.75
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord (1997) 1.43
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve (1994) 1.28
Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve (1992) 1.23
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest (1994) 1.22
Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol (1997) 1.22
Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve (1998) 1.18
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol Ther (2001) 1.17
In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell Res (2000) 1.16
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc (1992) 1.11
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther (1995) 1.11
Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther (2007) 1.08
Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther (2010) 1.07
Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts. Muscle Nerve (1991) 1.05
Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve (1994) 1.03
Non-uniform release at the frog neuromuscular junction: evidence of morphological and physiological plasticity. Brain Res (1987) 1.03
Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant (1997) 1.02
Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant (2007) 0.95
Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol (1995) 0.95
Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant (2003) 0.95
Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res (2006) 0.94
Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng (2000) 0.93
Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol (2000) 0.92
Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc (1991) 0.92
Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol (1996) 0.91
Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem Biophys Res Commun (1998) 0.91
A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant (2007) 0.90
Transfection of large plasmids in primary human myoblasts. Gene Ther (2001) 0.90
Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. Transplant Proc (1993) 0.90
Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release. Neuroscience (1991) 0.89
Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther (2001) 0.89
Immune reactions after myoblast transplantation in mouse muscles. Transplant Proc (1992) 0.88
Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy. Clin Sci (Lond) (1991) 0.88
Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transplant (1994) 0.88
Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol (1999) 0.88
Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem Cell Biol (2003) 0.87
Depression and frequency facilitation at a synapse in Aplysia californica: evidence for regulation by availability of transmitter. Brain Res (1974) 0.87
Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem (1993) 0.86
Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant (1999) 0.86
Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig. Hum Gene Ther (1996) 0.86
Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem (1993) 0.86
Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Cell Transplant (2009) 0.86
Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin prduced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve (1998) 0.85
Non-uniform distribution of miniature endplate potential amplitudes along the length of the frog neuromuscular junction. Neurosci Lett (1987) 0.85
Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases. Cell Transplant (2001) 0.85
Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Gene Ther (2006) 0.85
Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve (1995) 0.84
Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation (1995) 0.84
Frequency facilitation and post-tetanic potentiation of a unitary synaptic potential in Aplysia californica are limited by different processes. Brain Res (1976) 0.84
Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul Disord (2002) 0.84
Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve (1995) 0.84
Is the MEPP due to the release of one vesicle or to the simultaneous release of several vesicles at one active zone? Brain Res (1983) 0.82
Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve (1995) 0.82
Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue. Transplantation (1999) 0.82
Scale-up of a myoblast culture process. J Biotechnol (2001) 0.82
Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application. Gene Ther (2000) 0.82
Identification of homozygous and heterozygous dy2J mice by PCR. Neuromuscul Disord (2000) 0.82
Normal myoblast implantation in MDX mice prevents muscle damage by exercise. Biochem Biophys Res Commun (1998) 0.81
Is dystrophin present in the nerve terminal at the neuromuscular junction? An immunohistochemical study of the heterozygote dystrophic (mdx) mouse. Synapse (1991) 0.81
Distribution of spontaneous release along the frog neuromuscular junction. Neurosci Lett (1984) 0.81
Myoblast allotransplantation in primates. Muscle Nerve (1995) 0.80
Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J Cell Biol (1996) 0.80
Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation (1998) 0.80
Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles. Gene Ther (1999) 0.80
Dystrophin-like immunoreactivity in monkey and human brain areas involved in learning and motor functions. Neurosci Lett (1992) 0.80
Efficient myoblast transplantation in mice immunosuppressed with monoclonal antibodies and CTLA4 Ig. Transplant Proc (1997) 0.80
Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast. Muscle Nerve (1998) 0.80
A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction. Synapse (1992) 0.80
Fast turnover of clear vesicle membrane in frog sympathetic ganglion. Neuroscience (1986) 0.80
Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction. Synapse (1989) 0.80
Interrelation between MEPP amplitude and MEPP frequency in different regions along the frog neuromuscular junction. Brain Res (1987) 0.79
Successive injections in mdx mice of myoblasts grown with bFGF. Neuromuscul Disord (1996) 0.79
Marked prolongation of post-tetanic potentiation at a transition temperature in its adaption. Nature (1975) 0.79
Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice. Acta Neuropathol (1996) 0.79
A monoclonal antibody to conotoxin reveals the distribution of a subset of calcium channels in the rat cerebellar cortex. Brain Res Mol Brain Res (1991) 0.79
Heterosynaptic inhibition modifies the presynaptic plasticities of the transmission process at the synapse in Aplysia californica. Brain Res (1976) 0.79
Complement deposition and cell death after myoblast transplantation. Cell Transplant (1999) 0.79
Inflammatory damage following first-generation replication-defective adenovirus controlled by anti-LFA-1. J Leukoc Biol (1997) 0.79
Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Biochem Biophys Res Commun (1998) 0.79
Myoblast transplantation in non-dystrophic dog. Neuromuscul Disord (1998) 0.79
Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts. Gene Ther (1998) 0.79
The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation. Exp Cell Res (2002) 0.79
Dopamine, serotonin and related compounds: presynaptic effects on synaptic depression, frequency facilitation, and post-tetanic potentiation at a synapse in Aplysia californica. Brain Res (1976) 0.79
Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice. Transplantation (1996) 0.78
Incorporation of vesicular antigens into the presynaptic membrane during exocytosis at the frog neuromuscular junction: a light and electron microscopy immunochemical study. Neuroscience (1987) 0.78
Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments. Transplant Proc (1994) 0.78
Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID mice. Biochem Biophys Res Commun (2000) 0.78
Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve (1994) 0.78
Cholinergic agents affect two receptors that modulate transmitter release at a central synapse in Aplsia californica. Brain Res (1975) 0.78
Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy. J Neuropathol Exp Neurol (1999) 0.77
Male-specific competitive PCR for the quantification of transplanted cells in mice. Biotechniques (1999) 0.77
Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblasts. Hum Gene Ther (2000) 0.77
Resting and stimulated values of model parameters governing transmitter release at a synapse in Aplysia californica. Brain Res (1976) 0.77
Localization of dystrophin in the Purkinje cells of normal mice. Neurosci Lett (1992) 0.77
Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice. Transplant Proc (1994) 0.76
An electron microscope study of synaptic contacts in the abdominal ganglion of Aplysia californica. J Comp Neurol (1979) 0.76
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. Transplantation (2001) 0.76
The effects of hemicholinium-3 on synaptic depression, facilitation, and post-tetanic potentiation at an identified synapse of Aplysia californica. Can J Physiol Pharmacol (1980) 0.76
Boutons originating from the same axon do not participate equally in synaptic transmission. Neurosci Lett (1982) 0.76
Mosaic expression of dystrophin in the cerebellum of heterozygote dystrophic (mdx) mice. Neuromuscul Disord (1992) 0.75